Android app Apple app link

Iovance Biotherapeutics, Inc. (IOVA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.01
Day's range
$5.63

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/30/2026 Wells Fargo Nick Abbott $18.00 $14.45   24.57%
09/29/2026 H.C. Wainwright Joseph Pantginis $20.00 $14.06   42.25%
08/20/2026 UBS David Dai $7.00 $7.99   -12.39%
08/07/2026 Robert W. Baird Collen Kusy $6.00 $6.21   -3.38%
02/05/2026 Goldman Sachs Andrea Newkirk $2.00 $2.44   -18.03%
05/16/2025 UBS David Dai $2.00 $1.66   20.48%
01/31/2025 Piper Sandler Joseph Catanzaro $7.50 $5.85   28.21%
10/23/2024 UBS David Dai $17.00 $9.82   73.12%
08/09/2024 Stifel Nicolaus Benjamin Burnett $23.00 $3.97   479.35%
08/09/2024 Robert W. Baird Colleen Kusy $24.00 $3.97   504.53%
07/28/2024 Piper Sandler Joseph Catanzaro $10.00 $9.25   8.11%
06/20/2024 JMP Securities Reni Benjamin $23.00 $4.00   475%
05/31/2024 Stifel Nicolaus Benjamin Burnett $28.00 $4.44   530.63%
03/14/2024 Piper Sandler Joseph Catanzaro $19.00 $14.21   33.71%
12/08/2022 Goldman Sachs Madhu Kumar $6.00 $7.17   -16.32%
11/20/2022 Piper Sandler Joseph Catanzaro $11.00 $6.62   66.16%
04/04/2022 Robert W. Baird Colleen M. Kusy $30.00 $16.56   81.16%
01/04/2022 Wells Fargo Nick Abbott $25.00 $16.82   48.63%
05/18/2021 Barclays Peter Lawson $40.00 $16.33   144.95%

Iovance Biotherapeutics Inc FAQ's

Iovance Biotherapeutics Inc has been rated by research analysts at Robert W. Baird, Wells Fargo, H.C. Wainwright, Jefferies, Goldman Sachs, Barclays in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.